PremiumTLSI

Executives are unusually accumulating this biotech stock while analysts see triple-digit upside!

TriSalus Life Sciences, Inc, a company developing technology for treating cancerous tumors, is seeing significant purchases by executives after a mixed quarterly report.

By the SpyStocks desk · 3mo ago · 3 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Hot stock alerts, straight to Telegram

Real-time buys, sweeps, and trading halts from the desk. Free to join.

Join the channel

Executives are unusually accumulating this biotech stock while analysts see triple-digit upside!

The rest is for members

Hot stock alerts, straight to Telegram

Related Stories

Major move in Somnigroup International: CEO buys almost $1.9 million, day after major deal completion

Major move in Somnigroup International: CEO buys almost $1.9 million, day after major deal completion

Will Pfizer do a Moderna for investors?

Will Pfizer do a Moderna for investors?

Intriguing activity in Madison Air

Intriguing activity in Madison Air